During the past decade, Shahram Jacobs MD, Inc. conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shahram Jacobs MD, Inc." #1 sponsor was "Acrotech Biopharma Inc." with 1 trials, followed by "Allergan" with 1 trials sponsored, "Boston Pharmaceuticals" with 1 trials sponsored, "Momenta Pharmaceuticals, Inc." with 1 trials sponsored and "RedHill Biopharma Limited" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Shahram Jacobs MD, Inc." are "Irritable Bowel Syndrome With Diarrhea" (2 trials), "Atopic Dermatitis" (1 trials), "Chronic Plaque Psoriasis" (1 trials), "Diarrhea-predominant Irritable Bowel Syndrome" (1 trials) and "Psoriasis" (1 trials). Many other conditions were trialed in "Shahram Jacobs MD, Inc." in a lesser frequency.

Most popular intervention types in "Shahram Jacobs MD, Inc." are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "BEKINDA" (1 trials), "BOS-589" (1 trials), "Difamilast" (1 trials) and "Eluxadoline" (1 trials). Other intervention names were less common.

The vast majority of trials in "Shahram Jacobs MD, Inc." are 5 trials for "All" genders.

Currently, there are NaN active trials in "Shahram Jacobs MD, Inc.". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Shahram Jacobs MD, Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Shahram Jacobs MD, Inc., 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".